Health ❯ Healthcare ❯ Regulatory Agencies

FDA

Drug Approval Process Vaccine Approval Process Drug Warnings Recalls Product Recalls Drug Evaluation Drug Recalls Emergency Use Authorization Vaccine Recommendations Leadership Changes Drug Safety Drug Approval Processes Recall Notices Drug Approvals FDA Commissioner Center for Biologics Evaluation and Research Product Warnings Recalls and Alerts Approval Process Vaccine Regulation Vaccine Warnings Drug Approval Adverse Event Reporting Drug Enforcement Safety Guidelines Preservatives in Vaccines Leadership Decisions Import Alerts Transparency Initiatives Drug Labeling Vaccine Oversight Drug Safety Guidelines Drug Monitoring Accelerated Approval Pathways Public Health Alerts Vaccine Licensing Medication Shortage Database Drug Rejection Drug Safety Reviews Post-Marketing Surveillance Mammography Quality Standards Act Emergency Declarations Drug Shortage Declarations Public Health Initiatives Mifepristone Workforce Issues Public Health Regulation

FDA Sends 18 Warning Letters to Websites Selling Unapproved Botox-Like Injectables

Regulators cite injury reports warning of botulism risks from unapproved toxins.

FDA Issues Safety Alert on RF Microneedling Injuries

Teva, Amerisource Pull 580,000+ Prazosin Bottles as FDA Flags Nitrosamine Contamination

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy